Literature DB >> 8901806

Herman Award Lecture, 1996: relation of metabolic studies to clinical nutrition--the example of burn injury.

R R Wolfe1.   

Abstract

The optimal nutritional support of critically ill patients should be based on the metabolic response. Therefore, we performed a series of experiments in patients using stable isotopic tracers designed to elucidate the responses of glucose, fatty acids, and protein metabolism in severely burned patients. Glucose production was elevated above normal as a result of an increase in glucagon concentration. The peripheral hypoglycemic action of insulin was diminished, as was its effectiveness in suppressing endogenous glucose production, but the intracellular capacity to oxidize glucose was not impaired. Lipolysis was stimulated by beta 2-adrenergic stimulation to a much greater extent than was fatty acid oxidation, with the result being an increase in the recycling of fatty acids secreted in very-low-density lipoproteins. Muscle protein catabolism was accelerated in severely burned patients, leading to a progressive loss of lean body mass that was not prevented by nutritional support alone. The ineffectiveness of nutritional support for muscle was due to alterations in amino acid transmembrane transport kinetics that favored efflux. Treatment with exogenous insulin stimulated inward amino acid transport and muscle protein synthesis. Extrapolation from our current knowledge of metabolism to clinical treatment indicates that nonprotein energy should be provided largely in the form of carbohydrate. If hyperglycemia ensues, exogenous insulin will further increase the anabolic response in muscle. Protein requirements can be met with 1.5 g protein.kg-1.d-1. Treatment with anabolic hormones may ultimately be the most effective way in which to optimize the response to nutritional support.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8901806     DOI: 10.1093/ajcn/64.5.800

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  10 in total

1.  Diabetes does not influence selected clinical outcomes in critically ill burn patients.

Authors:  Chaitanya K Dahagam; Alejandra Mora; Steven E Wolf; Charles E Wade
Journal:  J Burn Care Res       Date:  2011 Mar-Apr       Impact factor: 1.845

2.  Insulin therapy in burn patients does not contribute to hepatic triglyceride production.

Authors:  A Aarsland; D L Chinkes; Y Sakurai; T T Nguyen; D N Herndon; R R Wolfe
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

3.  The contribution of muscle to whole-body protein turnover throughout the course of burn injury in children.

Authors:  Kathrina Prelack; Yong Ming Yu; Maggie Dylewski; Martha Lydon; Robert L Sheridan; Ronald G Tompkins
Journal:  J Burn Care Res       Date:  2010 Nov-Dec       Impact factor: 1.845

4.  Improved net protein balance, lean mass, and gene expression changes with oxandrolone treatment in the severely burned.

Authors:  Steven E Wolf; Steven J Thomas; Mohan R Dasu; Arny A Ferrando; David L Chinkes; Robert R Wolfe; David N Herndon
Journal:  Ann Surg       Date:  2003-06       Impact factor: 12.969

5.  A geriatric patient with major burns:case report.

Authors:  F Uygur; N Noyan; E Ulkür; B Celiköz
Journal:  Ann Burns Fire Disasters       Date:  2008-03-31

6.  Acute dichloroacetate administration increases skeletal muscle free glutamine concentrations after burn injury.

Authors:  A A Ferrando; D L Chinkes; S E Wolf; S Matin; D N Herndon; R R Wolfe
Journal:  Ann Surg       Date:  1998-08       Impact factor: 12.969

7.  What's new in Emergencies, Trauma, and Shock? Nitrogen balance in critical patients on enteral nutrition.

Authors:  Luigi Beretta; Simona Rocchetti; Marco Braga
Journal:  J Emerg Trauma Shock       Date:  2010-04

Review 8.  The role of hyperglycemia in burned patients: evidence-based studies.

Authors:  Gabriel A Mecott; Ahmed M Al-Mousawi; Gerd G Gauglitz; David N Herndon; Marc G Jeschke
Journal:  Shock       Date:  2010-01       Impact factor: 3.454

9.  Insulin resistance is a significant determinant of sarcopenia in advanced kidney disease.

Authors:  Serpil M Deger; Jennifer R Hewlett; Jorge Gamboa; Charles D Ellis; Adriana M Hung; Edward D Siew; Cindy Mamnungu; Feng Sha; Aihua Bian; Thomas G Stewart; Naji N Abumrad; T Alp Ikizler
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-06-12       Impact factor: 4.310

Review 10.  Nutrition in the intensive care unit.

Authors:  C Weissman
Journal:  Crit Care       Date:  1999-09-17       Impact factor: 9.097

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.